High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

NCT05943691 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

ITP - Immune Thrombocytopenia

Interventions

DRUG: hetrombopag 5mg po qd
DRUG: High-dose Dexamethasone

Sponsor

Shandong University